Anti-Counterfeiting Interim Step Should Be Paper Pedigree, PhRMA Says
Executive Summary
Drug products should contain paper pedigrees as an interim anti-counterfeit measure, the Pharmaceutical Research & Manufacturers of America said at FDA's Oct. 15 Anti-Counterfeit Drug Initiative public meeting in Bethesda, Md
You may also be interested in...
National Licensing Standard For Wholesale Distributors Gains Momentum
In the face of counterfeit drug problems and questions over the safety of the nation's drug supply, momentum appears to be building for a national wholesale distributor licensing standard
National Licensing Standard For Wholesale Distributors Gains Momentum
In the face of counterfeit drug problems and questions over the safety of the nation's drug supply, momentum appears to be building for a national wholesale distributor licensing standard
Drug Distributor Consolidation May Call For Change In Oversight, HDMA Says
Consolidation of the drug distribution industry could warrant a move away from state-based regulation, Healthcare Distribution Management Association Senior VP-Government Affairs Scott Melville said June 15 at HDMA's Distribution Management Conference in Orlando, Fla